Evaluation of the metastatic status of lymph nodes identified using axillary reverse mapping in breast cancer patients

World Journal of Surgical Oncology

Volumn 10, Issue , 2012, Pages

  Ikeda, Katsumi ^a   Ogawa, Yoshinari ^a   Komatsu, Hisateru ^a   Mori, Yoshihiro ^a   Ishikawa, Akira ^a   Nakajima, Takayoshi ^a   Oohira, Gou ^a   Tokunaga, Shinya ^a   Fukushima, Hiroko ^a   Inoue, Takeshi ^a  

^a OSAKA CITY GENERAL HOSPITAL   (Japan)

Author keywords

Axillary reverse mapping; Breast cancer; Fine needle aspiration cytology; Fluorescence image

Indexed keywords

INDOCYANINE GREEN;

ADULT; AGED; ARTICLE; ASPIRATION CYTOLOGY; AXILLARY LYMPH NODE; AXILLARY VEIN; BRACHIAL PLEXUS; BREAST CANCER; CANCER PATIENT; CONTROLLED STUDY; FLUORESCENCE IMAGING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGING SYSTEM; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; PARTIAL MASTECTOMY; SENTINEL LYMPH NODE BIOPSY;

ARM; AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; LYMPHEDEMA; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY;

EID: 84868220292     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-10-233     Document Type: Article

References (20)

1. Giuliano AE, Hunt KK, Ballman KV, Beitsch P, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, McCall LM, Morrow M. Axillary dissection vs. no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 2011, 305:569-575. 10.1001/jama.2011.90, 21304082.
2. Clarke M, Collins R, Darby S, Elphinstone P, Evans E, Godwin J, Gray R, Hicks C, James S, MacKinnon E, McGale P, McHugh T, Peto R, Taylor C, Wang Y, . Early Breast Cancer Trialists' Collaborative Group (EBCTCG) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials. Lancet 2005, 366:2087-2106. Early Breast Cancer Trialists' Collaborative Group (EBCTCG).
3. Petrek JA, Haalan MC. Incidence of breast carcinoma-related lymphedema. Cancer 1988, 83:2776-2781.
4. Petrek JA, Senie RT, Peters M, Rosen PP. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer 2001, 92:1368-1377. 10.1002/1097-0142(20010915)92:6<1368::AID-CNCR1459>3.0.CO;2-9, 11745212.
5. Nesvold IL, Reinersten KV, Fossa SD, Dahl AA. The relation between arm/shoulder problem and quality of life in breast cancer survivors: a cross-sectional and longitudinal study. J Cancer Surviv 2011, 5:62-72. 10.1007/s11764-010-0156-4, 3040353, 20972640.
6. Nishio M, Ogawa Y, Ikeda K, Okutani Y, Nagahara H, Sakurai K, Tokunaga S, Hamakawa T, Nishiguchi Y, et al. Lymphedema following axillary lymph node dissection for breast cancer - about its etiology and risk factors. Jpn J Breast Cancer 2007, 22:469-474.
7. Michael S, Charikleia S, Konstantinos K. Lymphedema and breast cancer: a review of the literature. Breast Cancer 2011, 18:174-180. 10.1007/s12282-010-0246-1, 21331463.
8. Thompson M, Korourian S, Henry-Tillman R, Adkins L, Mumford S, Westbrook KC, Klimberg VS. Axillary reverse mapping (ARM): A new concept to identify and enhance lymphatic preservation. Ann Surg Oncol 2007, 14:1890-1895. 10.1245/s10434-007-9412-x, 17479341.
9. Nos C, Leiseur B, Clough KB, Lecuru F. Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast cancer patients requiring an axillary dissection. Ann Surg Oncol 2007, 14:2490-2496. 10.1245/s10434-007-9450-4, 17549570.
10. Nos C, Kaufmenn G, Clough KB, Collignon MA, Zerbib E, Cusumano P, Lecuru F. Combined axillary reverse mapping (ARM) technique for breast cancer patients requiring axillary dissection. Ann Surg Oncol 2008, 15:2550-2555. 10.1245/s10434-008-0030-z, 18618185.
11. Casabona F, Bogliolo S, Menada MV, Sala P, Villa G, Ferrero S. Feasibility of axillary reverse mapping during sentinel lymph node biopsy in breast cancer. Ann Surg Oncol 2009, 16:2459-2463. 10.1245/s10434-009-0554-x, 19506954.
12. Boneti C, Korourian S, Bland K, Cox K, Adkins LL, Henry-Tillman R, Klimberg VS. Axillary reverse mapping: mapping and preserving arm Lymphatics may be important in preserving lymphedema during sentinel lymph node biopsy. J Am Coll Surg 2008, 206:1038-1042. discussion 1042-1044, 10.1016/j.jamcollsurg.2007.12.022, 18471751.
13. Noguchi M, Yokoi M, Nakano Y. Axillary reverse mapping with indocyanine fluorescence imaging in patients with breast cancer. J Surg Oncol 2010, 101:217-221.
14. Bedrosian I, Babiera GV, Mittendorf EA, Kuerer HM, Pantoja L, Hunt KK, Krishnamurthy S, Meric-Bernstam F. A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients. Cancer 2010, 116:2543-2548.
15. Noguchi M. Axillary reverse mapping for breast cancer. Breast Cancer Res Treat 2010, 119:529-535. 10.1007/s10549-009-0578-8, 19842033.
16. Ciatto S, Brancato B, Risso G, Ambrogetti D, Bulgaresi P, Maddau C, Turco P, Houssami N. Accuracy of fine needle aspiration cytology (FNAC) of axillary lymph node as a triage test in breast staging. Breast Cancer Res Treat 2007, 103:85-91. 10.1007/s10549-006-9355-0, 17033920.
17. Sobin L, Gospodarowicz M, Witterkind C. TNM Classification of Malignant Tumors 2009, 181-191. Hoboken, NJ: Wiley, 7.
18. Han JW, Seo YJ, Choi JE, Kang SH, Lee SJ. The efficacy of arm node preserving surgery using axillary reverse mapping for preventing lymphedema in patients with breast cancer. J Breast Cancer 2012, 15:91-97. 10.4048/jbc.2012.15.1.91, 3318181, 22493634.
19. Alvarez S, Anorbe E, Alcorta P, Lopez F, Alonso I, Cortes J. Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: A systematic review. Am J Roentgenol 2006, 186:1342-1348.
20. Krishnamurthy S, Sneige N, Bedi DG, Edieken BS, Fornage BD, Kuerer HM, Singletary SE, Hunt KK. Role of ultrasound-guided fine needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma. Cancer 2002, 95:982-988. 10.1002/cncr.10786, 12209680.